§ PHARMACEUTICALS
USD · Pharmaceuticals

TARS

TARSUS PHARMACEUTICALS INC
USDSector · PharmaceuticalsBeta · 0.54
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
148 increased/new, 88 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B10.12EPS (TTM)-1.13
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Deep Track Capital, LP3.6M4.1%+20%
BlackRock, Inc.3.6M0.0%−6%
RTW INVESTMENTS, LP3.3M2.3%+0%
Paradigm Biocapital Advisors LP2.6M3.7%±0%
JANUS HENDERSON GROUP PLC2.2Mn/a+16%
Morgan Stanley1.9M0.0%n/a
◇ AC INTELLIGENCE

Top institutional owners for TARS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER98.1% · 0 holders
OTHER0.9% · 169 holders
QUALITY / COMPOUNDER0.4% · 20 holders
DEALER / BANK0.2% · 29 holders
PASSIVE / INDEX0.2% · 9 holders
SYSTEMATIC / QUANT0.1% · 9 holders
ACTIVIST0.0% · 1 holder
TACTICAL / MACRO0.0% · 2 holders
INCOME / DEFENSIVE0.0% · 16 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for TARS in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES